Insider Shareholders with Direct Ownership of Ligand Pharmaceuticals Inc (LGND)
This section provides a comprehensive overview of the insiders with direct ownership of Ligand Pharmaceuticals Inc (LGND). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LIGAND PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
John L Higgins
Director |
425,629 | 226,632 | 417,695 $83.9 Million | 31 |
Dec 28, 2022
Reduced 1.25%
|
| 109,219 | 102,445 | 162,187 $32.6 Million | 18 |
Nov 01, 2022
Reduced 11.13%
|
|
|
Todd C Davis
Chief Executive Officer |
130,779 | 20,466 | 161,337 $32.4 Million | 20 |
Dec 04, 2025
Reduced 0.08%
|
|
Jason Aryeh
Director |
12,570 | 10,000 | 71,323 $14.3 Million | 9 |
Dec 08, 2025
Added 2.77%
|
|
Matthew E Korenberg
President & COO |
124,504 | 105,438 | 50,777 $10.2 Million | 34 |
Sep 23, 2024
Reduced 0.39%
|
|
John W Kozarich
Director |
31,614 | 15,420 | 44,121 $8.86 Million | 21 |
Dec 01, 2025
Reduced 0.07%
|
|
Stephen L Sabba
Director |
31,614 | 22,971 | 33,793 $6.79 Million | 12 |
Jun 06, 2025
Added 3.45%
|
|
Andrew Reardon
CLO & Secretary |
45,889 | 27,108 | 30,811 $6.19 Million | 24 |
Aug 10, 2025
Reduced 4.12%
|
|
John L Lamattina
Director |
16,657 | 11,420 | 30,724 $6.17 Million | 11 |
Nov 07, 2025
Reduced 6.21%
|
| 2,634 | 1,004 | 28,820 $5.79 Million | 4 |
Nov 01, 2022
Reduced 3.37%
|
|
|
Octavio Espinoza
Chief Financial Officer |
59,999 | 43,750 | 28,567 $5.74 Million | 33 |
Dec 16, 2025
Added 0.63%
|
| 18,839 | 36,129 | 23,825 $4.79 Million | 10 |
Nov 01, 2022
Reduced 33.39%
|
|
|
Nancy Ryan Gray
Director |
11,808 | 7,505 | 8,094 $1.63 Million | 8 |
Nov 07, 2025
Reduced 27.14%
|
|
Jason Haas
Director |
5,353 | 0 | 6,606 $1.33 Million | 4 |
Jun 06, 2025
Added 15.47%
|
|
Martine Zimmermann
Director |
4,746 | 303 | 4,443 $892,420 | 5 |
Sep 22, 2025
Reduced 2.52%
|
| 1,634 | 1,004 | 2,892 $580,887 | 3 |
Nov 01, 2022
Reduced 25.77%
|
|
| 2,165 | 1,004 | 1,161 $233,198 | 3 |
Nov 01, 2022
Reduced 46.37%
|
|